All these findings, in mouse and human, indicate that hypersensitivity to GM-CSF, as manifested by growth factor-independent CFU-GM growth in vitro, is caused by molecular aberrations of the RAS-pathway which may be a major driver in CMML pathogenesis, in particular in MP-CMML. Here, CSF2 is linked to chronic myelomonocytic leukemia.